Guideline update

Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate

GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up

Pregnancy complications demand long-term cardiovascular care

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Half of CKM patients go untreated and most fail control
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer

Ebola Funding Finally Moves. The Virus Has Already Moved Faster.

Tourette Care May Finally Get a New FDA Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
